| Patent application number | Description | Published |
|---|
| 20080200681 | Processes for preparing palonosetron salts - The present invention provides processes for preparing Palonosetron salts, especially, the hydrochloride salt and intermediates used to prepare Palonosetron salts. | 08-21-2008 |
| 20080207904 | Imatinib base, and imatinib mesylate and processes for preparation thereof - The present invention provides crystalline forms of imatinib base, imatinib base free of desmethyl imatinib, and imatinib mesylate free of desmethyl imatinib mesylate, processes of their preparation and pharmaceutical compositions of imatinib mesylate. | 08-28-2008 |
| 20090192200 | POLYMORPHS OF SORAFENIB TOSYLATE AND SORAFENIB HEMI-TOSYLATE, AND PROCESSES FOR PREPARATION THEREOF - Provided are sorafenib hemi-tosylate, polymorphs thereof, polymorphs of sorafenib tosylate, preparation thereof and pharmaceutical compositions thereof. | 07-30-2009 |
| 20090209754 | Process for the preparation of capecitabine - The present application relates to an improved process for the preparation of capecitabine. | 08-20-2009 |
| 20090253913 | Process for the preparation of sorafenib and salts thereof - Methods for the synthesis of the N-carbamoyl imidazole (I) and its 1:1 adduct with imidazole are provided. Methods for the preparation of these crystalline intermediates in a high state of purity are also provided. These intermediates react cleanly under mild conditions to produce sorafenib in high yield and purity, without generating difficult-to-remove impurities. | 10-08-2009 |
| 20100016593 | CRYSTALLINE FORMS OF PALONOSETRON HYDROCHLORIDE - The present invention provides crystalline forms of Palonosetron hydrochloride, processes for their preparation and pharmaceutical compositions containing such crystalline forms of Palonosetron HCl. | 01-21-2010 |
| 20100130458 | Polymorphs of fluticasone furoate and process for preparation thereof - Provided are polymorphs of fluticasone furoate and processes for preparation thereof. | 05-27-2010 |
